Your browser doesn't support javascript.
loading
First-in-human administration of terbium-161-labelled somatostatin receptor subtype 2 antagonist ([161Tb]Tb-DOTA-LM3) in a patient with a metastatic neuroendocrine tumour of the ileum.
Fricke, Julia; Westerbergh, Frida; McDougall, Lisa; Favaretto, Chiara; Christ, Emanuel; Nicolas, Guillaume P; Geistlich, Susanne; Borgna, Francesca; Fani, Melpomeni; Bernhardt, Peter; van der Meulen, Nicholas P; Müller, Cristina; Schibli, Roger; Wild, Damian.
Afiliación
  • Fricke J; Division of Nuclear Medicine, University Hospital Basel, Basel, Switzerland.
  • Westerbergh F; Department of Medical Radiation Sciences, Institute of Clinical Sciences, Sahlgrenska Academy at University of Gothenburg, Gothenburg, Sweden.
  • McDougall L; Division of Nuclear Medicine, University Hospital Basel, Basel, Switzerland.
  • Favaretto C; Division of Nuclear Medicine, University Hospital Basel, Basel, Switzerland.
  • Christ E; Center for Radiopharmaceutical Sciences, Paul Scherrer Institute (PSI), Villigen, Switzerland.
  • Nicolas GP; ENETS Center of Excellence for Neuroendocrine and Endocrine Tumours, University Hospital Basel, Basel, Switzerland.
  • Geistlich S; Division of Endocrinology, University Hospital Basel, Basel, Switzerland.
  • Borgna F; Division of Nuclear Medicine, University Hospital Basel, Basel, Switzerland.
  • Fani M; ENETS Center of Excellence for Neuroendocrine and Endocrine Tumours, University Hospital Basel, Basel, Switzerland.
  • Bernhardt P; Center for Radiopharmaceutical Sciences, Paul Scherrer Institute (PSI), Villigen, Switzerland.
  • van der Meulen NP; Center for Radiopharmaceutical Sciences, Paul Scherrer Institute (PSI), Villigen, Switzerland.
  • Müller C; Division of Radiopharmaceutical Chemistry, University Hospital Basel, Basel, Switzerland.
  • Schibli R; Department of Medical Radiation Sciences, Institute of Clinical Sciences, Sahlgrenska Academy at University of Gothenburg, Gothenburg, Sweden.
  • Wild D; Department of Medical Physics and Biomedical Engineering, Sahlgrenska University Hospital, Gothenburg, Sweden.
Eur J Nucl Med Mol Imaging ; 51(8): 2517-2519, 2024 Jul.
Article en En | MEDLINE | ID: mdl-38448550
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Receptores de Somatostatina / Tumores Neuroendocrinos / Neoplasias del Íleon Idioma: En Revista: Eur J Nucl Med Mol Imaging Asunto de la revista: MEDICINA NUCLEAR Año: 2024 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Receptores de Somatostatina / Tumores Neuroendocrinos / Neoplasias del Íleon Idioma: En Revista: Eur J Nucl Med Mol Imaging Asunto de la revista: MEDICINA NUCLEAR Año: 2024 Tipo del documento: Article